Agile’s Twirla FDA Approval Helps Shares

By |2020-04-19T10:25:58-04:00February 19th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , |

Agile Therapeutics, Inc. (NASDAQ:AGRX) announced FDA approval of its contraceptive [...]